Technology

Pivot Bio to Sponsor 9th International Nitrogen Conference

Published

2 years ago

February 5, 2024

Global meeting to focus on improving nitrogen management for sustainable growth

BERKELEY, Calif., Feb. 5, 2024 /PRNewswire/ — Pivot Bio, a leading sustainable agriculture company, is teaming up with the International Nitrogen Initiative to sponsor the 9th International Nitrogen Conference Feb. 5 to 8 at Guru Gobind Singh Indraprastha University in New Delhi. The summit will convene international nitrogen experts from around the world. Pivot Bio’s sponsorship supported the participation of more than 20 world-renowned scientists from Afghanistan, Australia, Bangladesh, Kenya, the Maldives, Nepal, Nigeria, Sri Lanka, Tunisia, Uganda and the United States, all of whom will consider how to move closer to INI’s goal of cutting nitrogen loss in half by 2050.

“The International Nitrogen Initiative is the world’s leading platform for improving nitrogen management.”

“The International Nitrogen Initiative is the world’s leading platform for improving nitrogen management,” says Pivot Bio CEO Chris Abbott. “It is a critical place for academics, policy makers and both emerging and traditional nitrogen providers to come together to help ensure the world’s farmers can continue to provide the food the world needs in the face of increasing volatility.”

By way of background, nitrogen is essential to plant growth, but until Pivot Bio arrived on the scene, farmers had only two choices for their crops: manure and synthetic fertilizer. In both cases, the all-important nitrogen was vulnerable to runoff and leaching, which lead to waste for farmers’ and loss that lead to environmental challenges. For example, surplus nitrogen can become nitrous oxide, the most potent of the three leading greenhouse gases.

By adhering directly to the roots of crops, Pivot Bio products can avoid this loss by, “spoon feeding the nutrient to the plant throughout its life cycle.”

As a result, Abbott said, “We welcomed with open arms the opportunity to help fund the INI conference and to share our own journey to give growers a better, more environmentally sustainable form of nitrogen.”

The invitation to sponsor the INI conference came from David Kanter, associate professor of environmental studies at New York University, INI chairperson and a member of the Pivot Bio Science Advisory Board.

“We are grateful for the funding from Pivot Bio, of course, but our gratitude goes far beyond the sponsorship. Pivot Bio has developed a promising way of keeping nitrogen with the crops that could see very important benefits for the environment and farmers’ bottom lines,” said Kanter. “We are very pleased to prominently include their voice at the world’s leading conference for nitrogen science and policy.”

Abbott and Karsten Temme, chief innovation officer and a co-founder of Pivot Bio, will address conference attendees in a 36-minute presentation that explains the workings of the company’s technological advances and why we need to continue finding a way to replace synthetic nitrogen fertilizers with products that take into account the needs of growers and the planet.

“We want to find ways to combine with other great ideas out there, to take the best new innovations and get them in the hands of growers as quickly as we can,” Temme said. “So, if we can prevent excess nitrogen from leaving a field in the form of nitrous oxide or nitrate runoff, for the grower, it’s better because 100% of the investment they make ends up getting converted into fuel for a crop.”

See their presentation online at https://www.youtube.com/watch?v=0tWs1z6LKls. Anyone interested in working with Pivot Bio on solutions that support our growers and our food system is invited to reach out to media@pivotbio.com.

About Pivot Bio
Pivot Bio is a leading sustainable agriculture company delivering farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility. Currently available in North America and soon in Brazil, the company’s products are a breakthrough innovation. They are among the industry’s most promising climate solutions because they deliver nitrogen to plants without the negative impacts of synthetic fertilizer. Our nitrogen is weatherproof, safer to handle, and does not leach or contribute to nitrous oxide pollution. By making this possible for the first time at scale, Pivot Bio is upending the 190 billion USD nitrogen market. Pivot Bio has been recognized twice by Time magazine on its annual list of best inventions, by Fast Company on its World Changing Ideas and World’s Most Innovative Companies lists, by CNBC in its Disruptor 50 list of private companies, and by Fortune on its Impact 20 list of startups driving social good. The company recently announced its fourth consecutive year of growth. For more information, visit PivotBio.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/pivot-bio-to-sponsor-9th-international-nitrogen-conference-302053599.html

SOURCE Pivot Bio, Inc

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

58 minutes ago

April 23, 2026

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

58 minutes ago

April 23, 2026

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

58 minutes ago

April 23, 2026

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system, helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company